Jul 28, 2016

Decreased Self-Appraisal Accuracy on Cognitive Tests of Executive Functioning Is a Predictor of Decline in Mild Cognitive Impairment

Frontiers in Aging Neuroscience
Carole S ScherlingHoward J Rosen

Abstract

Mild cognitive impairment (MCI) in older individuals is associated with increased risk of progression to dementia. The factors predicting progression are not yet well established, yet cognitive performance, particularly for memory, is known to be important. Anosognosia, meaning lack of awareness of one's impaired function, is commonly reported in dementia and is often also a feature of MCI, but its association with risk of progression is not well understood. In particular, self-appraisal measures provide an autonomous measure of insight abilities, without the need of an informant. The present study examined the utility of self-appraisal accuracy at baseline for predicting cognitive decline in 51 patients using an informant-free assessment method. Baseline task performance scores were compared to self-assessments of performance to yield a discrimination score (DS) for tasks tapping into memory and executive functions. Linear regression revealed that a larger DS for executive function tasks in MCI predicted functional decline, independent of age, education, and baseline memory and executive task scores. These findings indicate that objective estimates of self-appraisal can be used to quantify anosognosia and increase predictive a...Continue Reading

  • References
  • Citations4

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations4

Citations

Mentioned in this Paper

Study
Awareness
Executive Function
Self Administration
Mild Cognitive Disorder
Impaired Cognition
Dementia
Anosognosia
Memory
Linear Regression Body Surface Area Formula for Infants and Children

Related Feeds

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.